Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Kirk © who wrote (13134)	2/20/2022 9:31:11 PM
From: jpdunwell	2 Recommendations Recommended By h_ Winfastorlose Respond to of 26687

Clearly we know many who have taken ivermectin prophylactically who still got COVID and the recent study shows no magic benefit for taking it after being hospitalized. I guess we could say just about the same thing for the vaccines, no? Have you considered this recent study from the CDC? cdc.gov From that: for the Delta-dominant period- 46% unvaccinated, 54% vaccinated for Omicron-dominant period, 43% unvaccinated, 57% vaccinated Now, admittedly the US population is ~65% vaccinated, so there is some overweighting there, but the numbers are not overwhelming, and were quite surprising to me, coming from the CDC. I've seen even higher numbers for the vaccinated from Canada and Israel earlier. Regardless, my understanding on Ivermectin from the beginning has been that like Tamiflu, it needs to be taken early on (within 3 days of symptoms, I believe) in order to be most effective. Studies that neglect this (such as the Duke study currently underway that allows up to 10 days) are fundamentally flawed from the onset.